Boston Scientific falls after flagging lower usage of heart disease device

Boston Scientific

27/05/2026 15:14

** Shares of medical device maker Boston Scientific BSX.N fall 10.3% to $51.68
** CEO Michael Mahoney at a conference says the company has been seeing a decline in usage of its heart disease device, Watchman, for standalone procedures
** " ... we basically want to set an expectation of flat dollar growth from first quarter to second quarter and likely in the third quarter," says Mahoney
     **  Adds co is comfortable with its second-quarter and full-year forecasts even with the slowdown 
** In April, the company slashed its annual profit and revenue ‌growth forecasts
** Stock down ~45% YTD including session's move

 (Reporting by Sriparna Roy in Bengaluru)
 ((Sriparna.Roy@thomsonreuters.com;))